• TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Sharehold... AOL.com Wed, 08 Jul 2026 12:36:58 GMT
• Theravance Biopharma Price Target Raised to $17.00/Share From $15.00 by HC Wainwright & Co. Moomoo Tue, 07 Jul 2026 16:58:29 GMT
• Zymeworks' $929 Million Pivot: How a COPD Acquisition Redefines Its Future Kavout | AI Mon, 06 Jul 2026 03:46:37 GMT
• zymeworks to pay $17/share for theravance biopharma in $929m deal MSN Sat, 04 Jul 2026 23:30:19 GMT
• tbph sec filings - theravance bioph 10-k, 10-q, 8-k forms Stock Titan Sat, 04 Jul 2026 02:39:14 GMT
• Zymeworks to pay $17/share for Theravance Biopharma in $929M deal MSN Thu, 02 Jul 2026 16:51:22 GMT
• Theravance Biopharma Insider Sold Shares Worth $5,791,555, According to a Recent SEC Filing marketscreener.com Thu, 02 Jul 2026 08:24:50 GMT
• Theravance Biopharma(TBPH.US) 10% Shareholder Sells US$5.79 Million in Common Stock Moomoo Thu, 02 Jul 2026 02:37:34 GMT
• Funds tied to Eli Samaha trim Theravance Biopharma (TBPH) stake in open-market sales Stock Titan Wed, 01 Jul 2026 23:34:17 GMT
• Here’s Why Zymeworks Inc. Paid $929M For Theravance Biopharma (NASDAQ:ZYME) Seeking Alpha Wed, 01 Jul 2026 12:30:50 GMT
• Zymeworks to acquire Theravance Biopharma in deal worth $929m PMLiVE Wed, 01 Jul 2026 10:00:00 GMT
• tbph sec filings - theravance bioph 10-k, 10-q, 8-k forms Stock Titan Wed, 01 Jul 2026 09:12:09 GMT
• Arthur Cox advises Theravance Biopharma on its $929 million merger with Zymeworks Arthur Cox LLP Wed, 01 Jul 2026 08:22:33 GMT
• Zymeworks to Acquire Theravance Biopharma in $929 Million Transaction Global Legal Chronicle Wed, 01 Jul 2026 00:00:00 GMT
• zymeworks to pay $17/share for theravance biopharma in $929m deal MSN Tue, 30 Jun 2026 22:28:08 GMT
• Rick Winningham: Building Leaders Behind the Pipeline Pharmaceutical Executive Tue, 30 Jun 2026 18:39:20 GMT
• canadian zymeworks acquires american theravance biopharma for $929 million AKM.RU Tue, 30 Jun 2026 18:17:06 GMT
• After a three-decade legacy, Theravance agreed to a complex sale for less than $1 billion The Business Journals Tue, 30 Jun 2026 13:12:00 GMT
• key facts: zymeworks to buy theravance for $17/share; cvr, layoffs TradingView Tue, 30 Jun 2026 07:13:29 GMT
• Zymeworks agrees to buy Theravance Biopharma for $929m Pharmaceutical Technology Tue, 30 Jun 2026 07:00:00 GMT
• Theravance Stock Down 3% After Zymeworks Announces Buyout Yahoo Finance Tue, 30 Jun 2026 07:00:00 GMT
• Zymeworks to Acquire Theravance, Add COPD Treatment to Portfolio Contract Pharma Mon, 29 Jun 2026 19:36:39 GMT
• zymeworks expands into respiratory market with theravance buyout Investing News Network Mon, 29 Jun 2026 19:25:00 GMT
• theravance biopharma (tbph) downgraded to hold following $929m a GuruFocus Mon, 29 Jun 2026 19:03:21 GMT
• $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Theravance Biopharma, Inc. (NASDAQ: TBPH) PR Newswire Mon, 29 Jun 2026 17:36:00 GMT
• tbph stock alert: halper sadeh llc is investigating whether ther GuruFocus Mon, 29 Jun 2026 16:24:01 GMT
• zymeworks ceo on why the theravance deal is value for money Endpoints News Mon, 29 Jun 2026 15:54:49 GMT
• fair price or fast exit? scrutiny mounts over theravance biopharma sale BriefGlance Mon, 29 Jun 2026 15:19:00 GMT
• pharma m&a roundup: ipsen to acquire kartos therapeutics, zymeworks to acquire theravance biopharma Pharmaceutical Executive Mon, 29 Jun 2026 14:32:18 GMT
• Zymeworks to Acquire Theravance for $929 Million, But Discounted Price Triggers Shareholder Investigation finance.biggo.com Mon, 29 Jun 2026 14:25:00 GMT
• zymeworks makes bold move with $929m theravance biopharma buy BioXconomy Mon, 29 Jun 2026 14:05:49 GMT
• Ademi LLP Investigates Whether Theravance Biopharma, Inc. Is Obtaining a Fair Price for Public Shareholders Moomoo Mon, 29 Jun 2026 14:02:00 GMT
• Zymeworks Targets Long-Term Cash Generation Through Theravance Acquisition - Theravance Biopharma (NASDAQ Benzinga Mon, 29 Jun 2026 13:20:49 GMT
• zymeworks’ theravance buy adds yupelri to portfolio The Pharma Letter Mon, 29 Jun 2026 12:58:22 GMT
• zymeworks cuts deal to buy theravance for $929m in cash pharmaphorum Mon, 29 Jun 2026 12:09:26 GMT
• Why Zymeworks Is Acquiring Theravance Biopharma For $929 Million Pulse 2.0 Mon, 29 Jun 2026 12:07:32 GMT
• zymeworks to buy theravance for $929 million in push to expand beyond cancer ETPharma.com Mon, 29 Jun 2026 11:53:17 GMT
• zymeworks expands into copd, buying beleaguered theravance for $929m FirstWord PHARMA Mon, 29 Jun 2026 11:50:37 GMT
• Zymeworks to Acquire Theravance Biopharma in $929 Million Deal to Expand Commercial Portfolio citybiz Mon, 29 Jun 2026 11:50:11 GMT
• Zymeworks (ZYME) to Acquire Theravance Biopharma (TBPH) in $929M Deal GuruFocus Mon, 29 Jun 2026 11:16:32 GMT
• zymeworks to pay $17/share for theravance biopharma in $929m deal MSN Mon, 29 Jun 2026 10:52:10 GMT
• Zymeworks to acquire Theravance Biopharma for $929 million By Investing.com Investing.com Nigeria Mon, 29 Jun 2026 10:34:26 GMT
• theravance biopharma (tbph) reaches agreement for acquisition by zymeworks GuruFocus Mon, 29 Jun 2026 10:33:22 GMT
• theravance biopharma to be acquired by zymeworks for $17 per share plus cvr TradingView Mon, 29 Jun 2026 10:33:01 GMT
• zymeworks strikes $929 million deal for theravance biopharma TradingView Mon, 29 Jun 2026 10:21:31 GMT
• Zymeworks conclude un accordo da 929 milioni di dollari per l'acquisizione di Theravance Biopharma TradingView Mon, 29 Jun 2026 10:04:23 GMT
• THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT V... PR Newswire Mon, 29 Jun 2026 07:00:00 GMT
• Zymeworks expands beyond cancer with $929 million Theravance acquisition Reuters Mon, 29 Jun 2026 07:00:00 GMT
• Theravance, after clinical setbacks, agrees to $929M buyout BioPharma Dive Mon, 29 Jun 2026 07:00:00 GMT
• Zymeworks To Buy Theravance Biopharma In $929M Deal – A Look At What This Deal Means For TBPH Shareholders Yahoo Finance Mon, 29 Jun 2026 07:00:00 GMT
• Press Release: Zymeworks to Acquire Theravance Biopharma, Inc. Moomoo Mon, 29 Jun 2026 07:00:00 GMT
• Zymeworks to acquire Theravance Biopharma (NASDAQ: TBPH) in $929M cash and CVR deal Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• Zymeworks to Buy Theravance for Lung Disease Drug. Both Stocks Are Sliding. Barron's Mon, 29 Jun 2026 07:00:00 GMT
• BTIG downgrades Theravance Biopharma stock rating on Zymeworks deal Investing.com Mon, 29 Jun 2026 07:00:00 GMT
• Shareholder Alert: Ademi LLP investigates whether Theravance Biopharma, Inc. is obtaining a Fair Price for Public Shareholders PR Newswire Mon, 29 Jun 2026 07:00:00 GMT
• Zymeworks to acquire troubled biotech Theravance in $929M deal Endpoints News Mon, 29 Jun 2026 07:00:00 GMT
• Zymeworks conclut un accord de 929 millions de dollars avec Theravance Biopharma TradingView Mon, 29 Jun 2026 07:00:00 GMT
• Zymeworks Agrees To Buy Theravance Biopharma For $929 Million Finimize Mon, 29 Jun 2026 07:00:00 GMT
• Vancouver biotech Zymeworks buying Theravance for US$929M Business in Vancouver Mon, 29 Jun 2026 07:00:00 GMT
• Zymeworks offers US$929-million for COPD drug maker Theravance The Globe and Mail Mon, 29 Jun 2026 07:00:00 GMT
• why (tbph) price action is critical for tactical trading Stock Traders Daily Mon, 29 Jun 2026 05:28:02 GMT
• Theravance Biopharma, Inc.(NasdaqGM:TBPH) added to Russell 2000 Value-Defensive Index marketscreener.com Mon, 29 Jun 2026 02:42:52 GMT
• Theravance Biopharma, Inc.(NasdaqGM: TBPH) added to Russell 2000 Defensive Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• price to sales forward of theravance biopharma, inc. – nasdaq:tbph TradingView Sat, 27 Jun 2026 22:36:22 GMT
• price to book forward of theravance biopharma, inc. – nasdaq:tbph TradingView Fri, 26 Jun 2026 22:44:16 GMT
• price to earnings forward of theravance biopharma, inc. – nasdaq:tbph TradingView Fri, 26 Jun 2026 22:09:09 GMT
• enterprise value to ebitda forward of theravance biopharma, inc. – nasdaq:tbph TradingView Fri, 26 Jun 2026 21:11:15 GMT
• enterprise value to revenue forward of theravance biopharma, inc. – nasdaq:tbph TradingView Fri, 26 Jun 2026 13:02:57 GMT
• theravance biopharma inc actuals & estimates (nasdaq:tbph) TradingView Fri, 26 Jun 2026 08:29:27 GMT
• enterprise value to ebit forward of theravance biopharma, inc. – nasdaq:tbph TradingView Fri, 26 Jun 2026 00:43:16 GMT
• theravance biopharma inc (tbph) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• form 8k theravance biopharma inc for: 23 june by investing.com Investing.com Australia Wed, 24 Jun 2026 02:11:23 GMT
• form 4 theravance biopharma inc for: 23 june by investing.com Investing.com Nigeria Tue, 23 Jun 2026 22:26:24 GMT
• form 8k theravance biopharma inc for: 23 june by investing.com Investing.com Nigeria Tue, 23 Jun 2026 22:19:57 GMT
• theravance biopharma inc (tbph) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 10:42:04 GMT
• Theravance Biopharma (NASDAQ: TBPH) SVP awarded 18,750 Ordinary Shares Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Theravance Biopharma (NASDAQ: TBPH) sets exit terms for Ireland SVP Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• tbph stock slumps 30%, falls below 200-dma for first time in over 9 months as phase 3 study misses primary endpoint Stocktwits Fri, 19 Jun 2026 03:56:22 GMT
• btig maintains theravance biopharma(tbph.us) with buy rating, maintains target price $21 富途牛牛 Thu, 18 Jun 2026 17:27:03 GMT
• insider sell: rhonda farnum sells shares of theravance biopharma inc (tbph) GuruFocus Thu, 18 Jun 2026 04:58:25 GMT
• theravance biopharma svp rhonda farnum sells $218,167 in shares by investing.com Investing.com India Thu, 18 Jun 2026 04:12:22 GMT
• theravance biopharma inc (tbph) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 21:30:38 GMT
• theravance biopharma inc (tbph) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 21:22:47 GMT
• theravance biopharma inc (tbph) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 21:22:20 GMT
• theravance biopharma inc (tbph) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 21:21:53 GMT
• theravance biopharma inc (tbph) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 21:06:58 GMT
• theravance biopharma inc (tbph) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 18:26:23 GMT
• theravance biopharma inc (tbph) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 18:19:02 GMT
• Theravance Biopharma SVP Rhonda Farnum sells $218,167 in shares Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• Insider Sell: Rhonda Farnum Sells Shares of Theravance Biopharma Inc (TBPH) GuruFocus Wed, 17 Jun 2026 07:00:00 GMT
• theravance biopharma (tbph) svp rhonda farnum sells 13,314 shares at ~$16 Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• theravance biopharma (nasdaq: tbph) director granted shares and 13,398-share option Stock Titan Wed, 17 Jun 2026 01:59:28 GMT
• director dean j. mitchell granted shares and options at theravance (nasdaq: tbph) Stock Titan Wed, 17 Jun 2026 01:59:28 GMT
• director at theravance biopharma (tbph) receives new share and option awards Stock Titan Wed, 17 Jun 2026 01:59:27 GMT
• theravance biopharma (tbph) director susannah gray receives new share and option grants Stock Titan Wed, 17 Jun 2026 01:59:27 GMT
• director at theravance biopharma (nasdaq: tbph) receives new share and option grants Stock Titan Wed, 17 Jun 2026 01:37:19 GMT
• rick winningham: building leaders behind the pipeline Pharmaceutical Executive Tue, 16 Jun 2026 14:05:46 GMT
• Director at Theravance Biopharma (TBPH) receives new share and option awards Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Director Dean J. Mitchell granted shares and options at Theravance (NASDAQ: TBPH) Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Theravance Biopharma (TBPH) director Susannah Gray receives new share and option grants Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Theravance Biopharma (NASDAQ: TBPH) director granted shares and 13,398-share option Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Director at Theravance Biopharma (NASDAQ: TBPH) receives new share and option grants Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• here's our take on theravance biopharma inc (nasdaq:tbph) and glaxosmithkline plc (adr) (nyse:gsk)'s latest submission Yahoo Finance Tue, 16 Jun 2026 07:00:00 GMT
• theravance biopharma inc (tbph) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• theravance biopharma inc (tbph) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• theravance biopharma inc (tbph) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• 13,314 restricted shares listed for sale by TBPH (NASDAQ: TBPH) — Rule 144 notice Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• theravance biopharma shareholders back directors and governance plans The Globe and Mail Sat, 13 Jun 2026 07:00:00 GMT
• rick winningham: building leaders behind the pipeline Pharmaceutical Executive Fri, 12 Jun 2026 14:20:52 GMT
• theravance stock declines around 17% in three months: here's why MSN Fri, 12 Jun 2026 13:19:47 GMT
• jones trading initiates coverage of theravance biopharma (tbph) with buy recommendation MSN Fri, 12 Jun 2026 09:17:34 GMT
• theravance biopharma (nasdaq: tbph) investors approve directors, auditor and pay plan Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• tbph stock slumps 30%, falls below 200-dma for first time in over 9 months as phase 3 study misses primary endpoint Stocktwits Fri, 12 Jun 2026 00:26:44 GMT
• tbph stock slumps 30%, falls below 200-dma for first time in over 9 months as phase 3 study misses primary endpoint Stocktwits Tue, 09 Jun 2026 06:27:36 GMT
• avoiding lag: real-time signals in (tbph) movement Stock Traders Daily Sun, 07 Jun 2026 02:46:01 GMT
• tbph stock slumps 30%, falls below 200-dma for first time in over 9 months as phase 3 study misses primary endpoint Stocktwits Fri, 05 Jun 2026 16:45:28 GMT
• theravance stock declines around 17% in three months: here's why MSN Fri, 05 Jun 2026 09:21:35 GMT
• theravance stock declines around 17% in three months: here's why MSN Sat, 30 May 2026 04:15:56 GMT
• jonestrading maintains theravance biopharma(tbph.us) with buy rating, raises target price to $19 Moomoo Thu, 28 May 2026 11:58:13 GMT
• jonestrading maintains theravance biopharma(tbph.us) with buy rating, raises target price to $19 富途牛牛 Wed, 27 May 2026 07:00:00 GMT
Theravance Biopharma, Inc(NASDAQ:TBPH) 
Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and commercializes organ-selective medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstr...
Website: http://www.theravance.com
Founded: 2013
Full Time Employees: 316
Sector: Healthcare
Industry: Biotechnology